Full Text View
Tabular View
No Study Results Posted
Related Studies
Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder
This study is currently recruiting participants.
Verified January 2013 by Mount Sinai School of Medicine
Study NCT01371110   Information provided by Mount Sinai School of Medicine

First Received on June 7, 2011.   Last Updated on January 9, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obsessive Compulsive Disorder
Additional conditions recognized in this trial
Obsessive-Compulsive Disorder
More general conditions related to this trial
Anxiety Disorders
Mental Disorders
Interventions listed in this trial
Ketamine
Midazolam
More general drug interventions related to this trial
Adjuvants, Anesthesia
Analgesics
Anesthetics
Anesthetics, Dissociative
Anesthetics, General
Anesthetics, Intravenous
Anti-Anxiety Agents
Central Nervous System Agents
Central Nervous System Depressants
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
GABA Agents
GABA Modulators
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Wayne Goodman


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services